INHIBITION BY PIRENZEPINE OF NOCTURNAL GASTRIC ACID SECRETION IN DUODENAL ULCER PATIENTSCORINALDESI R; MIGLIOLI M; DANIOTTI S et al.1981; SCAND. J. GASTROENTEROL.; ISSN 0036-5521; NOR; DA. 1981; VOL. 16; NO 7; PP. 929-931; BIBL. 9 REF.Article

EFFICACY AND SAFETY OF PIRENZEPINE IN PEPTIC ULCER AND IN NON ULCEROUS GASTRODUODENAL DISEASES. A MULTICENTRE CONTROLLED CLINICAL TRIALGIORGI CONCIATO M; DANIOTTI S; FERRARI PA et al.1982; SCAND. J. GASTROENTEROL., SUPPL.; ISSN 0085-5928; NOR; DA. 1982; VOL. 17; NO 81; 40 P.; BIBL. DISSEM.Serial Issue

PIRENZEPINE VERSUS CIMETIDINE IN DUODENAL ULCER: A DOUBLE-BLIND, PLACEBO-CONTROLLED, SHORT-TERM CLINICAL TRIALBIANCHI PORRO G; DALMONTE PR; PETRILLO M et al.1982; DIGESTION; ISSN 0012-2823; CHE; DA. 1982; VOL. 23; NO 2; PP. 110-115; BIBL. 19 REF.Article

Effects of oral cimetropium bromide on esophageal motility in healthy subjects and in symptomatic patientsPANDOLFO, N; SPIGNO, L; BENSI, G et al.Current therapeutic research. 1990, Vol 48, Num 6, pp 1012-1020, issn 0011-393X, 9 p.Article

Manometric evaluation of cimetropium bromide activity in patients with the nutcracker oesophagusBASSOTTI, G; GABURRI, M; IMBIMBO, B. P et al.Scandinavian journal of gastroenterology. 1988, Vol 23, Num 9, pp 1079-1084, issn 0036-5521Article

Comparison of the gastric cytoprotective properties of atropine, ranitidine and PGE2 in ratsDEL SOLDATO, P; FOSCHI, D; VARIN, L et al.European journal of pharmacology. 1984, Vol 106, Num 1, pp 53-58, issn 0014-2999Article

A new criterion for selection of pharmacokinetic multiexponential equationsIMBIMBO, B. P; IMBIMBO, E; DANIOTTI, S et al.Journal of pharmaceutical sciences. 1988, Vol 77, Num 9, pp 784-789, issn 0022-3549Article

Safety and pharmacokinetics of mifentidine after increasing oral doses in healthy subjectsIMBIMBO, B. P; SEIBERLING, M; PEUCKERT, U et al.European journal of clinical pharmacology. 1988, Vol 35, Num 6, pp 673-676, issn 0031-6970Article

Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndromeCENTONZE, V; IMBIMBO, B. P; CAMPANOZZI, F et al.The American journal of gastroenterology. 1988, Vol 83, Num 11, pp 1262-1266, issn 0002-9270Article

Pirenzepine in erosive duodenitis: a controlled clinical trial versus ranitidineGUSLANDI, M; DANIOTTI, S; BALLARIN, E et al.Scandinavian journal of gastroenterology. 1985, Vol 20, Num 6, pp 751-755, issn 0036-5521Article

Influence of aluminium phosphate on esophageal motor activity in healthy subjectsBASSOTTI, G; IMBIMBO, B. P; DANIOTTI, S et al.Current therapeutic research. 1990, Vol 47, Num 3, pp 480-485, issn 0011-393XArticle

Pharmacokinetics of mifentidine after single and multiple oral administration to healthy volunteersIMBIMBO, B. P; URSO, R; THIEME, G et al.British journal of clinical pharmacology. 1988, Vol 26, Num 4, pp 407-413, issn 0306-5251Article

Transverse and sigmoid colon motility in healthy humans: effects of eating and of cimetropium bromideBASSOTTI, G; INBIMBO, B. P; GABURRI, M et al.Digestion. 1987, Vol 37, Num 1, pp 59-64, issn 0012-2823Article

Identification of muscarinic receptor subtype mediating colonic response to eatingNARDUCCI, F; BASSOTTI, G; DANIOTTI, S et al.Digestive diseases and sciences. 1985, Vol 30, Num 2, pp 124-128, issn 0163-2116Article

FEPRAZONE: ABSENCE OF HEMOLYTIC EFFECTS IN GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT SUBJECTSMELONI T; FORTELEONI G; SERRA M et al.1982; J. CLIN. PHARMACOL.; ISSN 0091-2700; USA; DA. 1982; VOL. 22; NO 8-9; PP. 418-420; BIBL. 4 REF.Article